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Abstract
GW182-family proteins are essential for microRNA-mediated translational repression and 
deadenylation in animal cells. Here we show that a conserved motif in the human GW182 paralog 
TNRC6C interacts with the C-terminal domain of polyadenylate binding protein 1 (PABC) and 
present the crystal structure of the complex. Mutations at the complex interface impair mRNA 
deadenylation in mammalian cell extracts, suggesting that the GW182-PABC interaction 
contributes to microRNA-mediated gene silencing.
MicroRNAs (miRNAs) are short endogenous RNAs that regulate a variety of eukaryotic cell 
processes, including cell growth, proliferation and differentiation. In Metazoa, miRNAs 
associate with Argonaute (Ago) proteins in miRNA-induced silencing complexes (miRISCs) 
to silence target mRNAs by a mechanism involving translational repression and concurrent 
stimulation of mRNA deadenylation and subsequent degradation1, 2.
In addition to Ago proteins, miRNA-mediated silencing requires proteins of the GW182 
family3. Tethering of GW182 proteins to mRNA reporters induces translational repression 
and mRNA decay in the absence of miRNAs and Ago, suggesting that GW182 proteins have 
silencing functions downstream of Ago4. A direct interaction between Ago and GW182, 
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mediated by glycine-tryptophan (GW) motifs found in the N-terminal region of GW182, is 
essential for miRNA-driven repression4–6. Apart from the N-terminal GW region, GW182 
proteins also contain a ubiquitin-associated (UBA) domain followed by a glutamine-rich (Q-
rich) region and an RNA recognition motif (RRM) domain. The sequence connecting the Q-
rich region and the RRM domain contains a conserved motif known as DUF (domain of 
unknown function) in mammalian GW182 proteins7 or motif III in Drosophila 
melanogaster dGW1828. The silencing activity of GW182 proteins can be attributed to a C-
terminal region containing the DUF and RRM domains7–10.
Polyadenylate-binding protein 1 (PABPC1) is present in Ago- and GW182-containing 
complexes immunoprecipitated from mammalian cells11–13. A bona fide miRNA 
coactivator in mammalian cells, PABPC1 directly interacts with the C-terminal silencing 
region of the human GW182 paralog TNRC6C13. Consistently, PABPC1 co-
immunoprecipitates with the silencing domain of Drosophila melanogaster dGW18214. 
Both full-length human TNRC6C and a fragment containing the DUF and RRM domains 
could be co-precipitated with glutathione-S-transferase (GST)-tagged PABPC1 from 
transiently transfected HEK293T cells (Supplementary Fig. 1). A TNRC6C fragment 
lacking the DUF domain did not interact with GST-PABPC1, indicating that the DUF 
domain in TNRC6C is required to mediate the TNRC6C-PABPC1 interaction.
To confirm a direct interaction, we performed in vitro co-precipitations using recombinant 
PABPC1 and a series of GST-fused TNRC6C fragments. Fragments encompassing residues 
1242-1601 and 1364-1601 efficiently precipitated PABPC1, while shorter fragments 
spanning residues 1418-1601, 1450-1601 and 1500-1601 did not, indicating that the DUF 
domain harbors a PABPC1 interaction site (Fig. 1a). Additionally, a TNRC6C fragment 
covering residues 1500-1690 also precipitated PABPC1, albeit less efficiently (lane 7, Fig. 
1a), but did not precipitate His-tagged T7 RNA polymerase (Supplementary Fig. 2). This 
suggests that the region in TNRC6C downstream of the RRM may constitute a second 
interaction site that binds PABPC1 independently of the DUF domain. The relative 
weakness of this interaction might explain why it was not detectable in co-precipitations 
from mammalian cell lysates.
A highly conserved motif in the DUF domain of TNRC6C resembles the PAM2 motif found 
in the PABPC1-interacting proteins 1 and 2 (Paip1 and Paip2)13, proteins that positively and 
negatively regulate translation, respectively15, 16 (Fig. 1b). The PAM2 motif is required for 
Paip1 and Paip2 to interact with the C-terminal domain of PABPC1 (hereafter referred to as 
PABC)17–19, implying a similar role for the DUF domain of GW182-family proteins in 
binding to the PABC domain13.
To obtain structural insights into the PABC-GW182 interaction, we determined the 1.5 Å 
crystal structure of a reconstituted complex consisting of the PABC domain (PABPC1 
residues 545-619) and an 18-amino acid peptide (residues 1382-1399) derived from the 
DUF domain of TNRC6C (Supplementary Methods and Supplementary Table 1). The DUF 
peptide forms a beta-turn hairpin that contacts helices α2 and α3 of the PABC domain (Fig. 
1c). The TNRC6C peptide binds to the same face of the PABC domain as recognized by the 
PAM2 motifs of both Paip1 and Paip218 (Supplementary Fig. 3a). However, in contrast to 
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the Paip1 and Paip2 complexes, the PABC domain does not appear to undergo a 
conformational change upon TNRC6C peptide binding, as helix α2 of the PABC domain 
remains uninterrupted in the TNRC6C-PABC complex (Supplementary Fig. 3b,c).
The 567 Å2 complex interface features an extensive network of hydrophobic and hydrogen-
bonding interactions. The side chains of the invariant TNRC6C residues Phe1389 and 
Trp1395 pack against each other and insert into a hydrophobic groove between helices α2 
and α3 of the PABC domain lined with the side chains of PABPC1 residues Phe567, 
Gly579, Thr582 and Leu586 (Fig. 2a). The beta-turn conformation adopted by the invariant 
TNRC6C residues Pro1391 and Gly1392 is specifically recognized via a hydrogen bond 
between the backbone amide of Gly1392 and the side chain of PABPC1 Glu564 and through 
a van der Waals contact between TNRC6C Pro1391 and PABPC1 Phe567. Additionally, the 
invariant TNRC6C Glu1388 forms a salt bridge with PABPC1 Lys580.
Alanine substitutions at positions Glu1388-Phe1389 or Trp1395-Lys1396 in the TNRC6C 
DUF domain abolished the interaction with PABPC1 in vitro (Supplementary Fig. 4). 
Corroborating this, a mutant TNRC6C fragment harboring alanine substitutions in place of 
the above dipeptides (1382-1690 Mut) could not be precipitated with GST-PABPC1 from 
HEK293T cell lysates, in contrast to a wild-type TNRC6C 1382-1690 fragment (Fig. 2b). 
This indicates that the TNRC6C-PABC interaction relies upon the presence of the invariant 
aromatic residues in the DUF domain.
Addition of Paip2-derived PAM2 peptide, which competes with TNRC6C for binding to the 
PABC domain, inhibits miRNA-mediated deadenylation of a let-7-targeted RNA in a 
mammalian in vitro extract that faithfully recapitulates miRNA-mediated repression13. To 
determine the significance of the TNRC6C-PABC interaction in miRISC-mediated 
deadenylation, we utilized the λN-BoxB system20 to tether recombinant wild-type and 
mutant TNRC6C fragments to an RNA reporter containing five BoxB stem-loops and a 98-
nucleotide poly(A) tail (5-BoxB-pA) in Krebs extract (Supplementary Fig. 5a,b). Wild-type 
GST-λNHA-TNRC6C(1382-1690) facilitated complete deadenylation of 5-BoxB-pA RNA 
within three hours (Fig. 2c, lane 12). Deadenylation was specific, as recombinant GST-
TNRC6C(1382-1690) lacking the λNHA tag was unable to mediate deadenylation of 5-
BoxB-pA RNA (Fig. 2c, lanes 3–6). In contrast, when a mutant construct carrying alanine 
substitutions of the invariant residues Glu1388-Phe1389 and Trp1395-Lys1396, GST-
λNHA-TNRC6C(1382-1690)Mut, was tethered to 5-BoxB-pA RNA (compare lane 18 to 
lane 12 in Fig. 2c), the rate and processivity of deadenylation was impaired. Taken together, 
these data suggest that GW182 must interact with PABPC1 via the DUF-PABC interface in 
order to mediate complete and efficient deadenylation of target mRNAs in vitro.
The structure of the TNRC6C-PABC complex reveals that key features of the intermolecular 
interface between TNRC6C and PABC are maintained throughout evolution. The PABC-
interacting motif (PIM) in the DUF domain is conserved in all three mammalian GW182 
paralogs, in Drosophila melanogaster and in the nematode Brugia malayi7 (Fig. 1c), 
implying functional conservation in miRISC activity. Our tethering experiments, and also 
previous studies in mammalian cell extracts13, indicate that the TNRC6C-PABC interaction 
is required for efficient miRISC-mediated mRNA deadenylation in vitro. Together, these 
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data suggest that the TNRC6C-PABC interaction contributes to the assembly of a repressive 
complex with target mRNAs that ultimately directs their deadenylation (Supplementary Fig. 
6).
In tethering assays in mammalian cells7 and in tethering as well as complementation assays 
in Drosophila S2 cells14, the DUF domain appears to be dispensable for GW182-mediated 
repression. It is possible that the role of the DUF domain in GW182-mediated silencing was 
overlooked in cell-based studies, as these experiments rely on protein overexpression, and 
the outcome of repression is assayed hours or days after target mRNA recognition. 
Intriguingly, recent co-immunoprecipitation experiments also suggest that Drosophila 
dGW182 interacts with the N-terminal RRM motifs of PABPC1 but not the C-terminal 
domain14. Conceivably, secondary interactions between GW182 proteins and PABPC1, 
potentially mediated by the polypeptide sequence downstream of the RRM in GW182, may 
be sufficient for repressive activity in mammalian cells and might be the dominant mode of 
PABPC1-GW182 interaction in Drosophila. Further studies will be required to resolve these 
apparent differences.
The results presented here extend our understanding of the central role of GW182-family 
proteins in miRNA-mediated gene silencing by elucidating the structural basis for GW182 
protein binding to PABPC1. The observation that GW182 proteins exploit a similar binding 
site in PABPC1 as Paip1 and Paip2 hints that miRNA-mediated silencing functions, at least 
in part, by mimicking protein interactions utilized by canonical protein regulators of 
translation.
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The DUF domain of TNRC6C interacts with the C-terminal domain of PABPC1. (a) Top: 
Domain structure of the human GW182 paralog TNRC6C and schematic representation of 
TNRC6C fragments. Bottom: Recombinant glutathione-S-transferase (GST)-fused TNRC6C 
fragments were immobilized on glutathione sepharose beads and incubated with 
recombinant full-length His-tagged human PABPC1. Precipitated proteins were resolved by 
SDS-PAGE and analyzed by staining with Coomassie blue and immunoblotting using an 
anti-PABPC1 antibody. (c) Alignment of GW182 DUF domain sequences from human (Hs), 
Drosophila melanogaster (Dm) and Brugia malayi (Bml) GW182 proteins with the PAM2 
motifs from human Paip2 and Paip1. Strictly conserved residues are highlighted in red; 
substantially conserved residues are orange. (d) Structure of the human TNRC6C (yellow)-
PABC (blue) complex.
Jinek et al. Page 6










Disruption of the TNRC6C-PABC interaction interferes with mRNA deadenylation in vitro. 
(a) A view of the interface between the TNRC6C DUF peptide (yellow, interacting side 
chains in stick format) and PABC domain (light blue surface, interacting residues 
highlighted in dark blue). Dashed lines indicate hydrogen-bonding interactions. (b) 
Hemagglutinin epitope (HA)-tagged wild type (WT) and mutant (Mut) TNRC6C fragments 
were transiently expressed in HEK293T cells. Cell lysates were incubated with recombinant 
GST-PABPC1 or GST-λN (negative control) immobilized on glutathione sepharose. 
Resulting complexes were analyzed by SDS-PAGE and anti-HA immunoblotting. (c) 5-
BoxB-pA RNA deadenylation in Krebs extract in the presence of recombinant wild-type 
(WT) or mutant (Mut) GST-λNHA-tagged TNRC6C(1382-1690), or a control construct 
lacking the λNHA tag. GST-λNHA-TNRC6C(1382-1690)Mut carries the same point 
mutations as 1382–1690Mut in Fig. 2b. –Poly(A) RNA was prepared by incubating 5-BoxB-
pA with oligo-d(T) and RNaseH.
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